CURRENT ISSUE

Genetic Engineering " Biotechnology News - Current Issue

(view larger image)

SUBSCRIBE

AD LINK

Visit GEN on Twitter!

GEN News Highlights

  • Print
  • Share
  • More GEN News Highlights

Feb 8 2008, 11:31 AM EST

Investigators Discover Melanoma-Suppressing Protein

GEN News Highlights

Howard Hughes Medical Institute (HHMI) researchers say that they have uncovered a protein that stops the growth of melanoma and turns it into a harmless mole. Also known as nevi,   moles and melanoma often result from the same genetic mutation, BRAF.

The biological pathway that differentiates the two, though, was previously unknown, report the scientists. BRAF is part of a signaling system that is important for cell growth and proliferation. The BRAF mutation found in nevi and melanoma increases the activity of the BRAF protein.

The investigators used RNAi to perform a genome-wide search for the proteins involved. They found 17 genes that were required for activated BRAF to induce either senescence or suicide, creating moles. The HHMI group say that three of the associated proteins are required for both the senescence and apoptosis pathways.

The identity of one of those proteins, insulin-like growth factor binding protein 7 (IGFBP7), surprised the researchers. Not much was known about IGFBP7, except that it was secreted. A secreted protein does not stay inside the cell that produces it but instead is released from the cell and moves through the blood to other cells.“We would have thought this process would be purely intracellular,” says Michael Green, M.D., Ph.D., one of the authors.

The team therefore focused their attention on IGFBP7 because its presence suggested something intriguing: If one otherwise healthy melanocyte begins expressing BRAF, the IGFBP7 it produces can enter cells around it, prompting lots of melanocytes to switch off.

The researchers exposed human melanoma cells in culture to recombinant IGFBP7. The protein had the same genetic code as the human version but was produced using genetically modified insect cells. The melanoma cells that were treated with IGFBP7 committed suicide.

The researchers also injected the protein into the bloodstream of mice on to which human melanoma tumors had been grafted. IGFBP7 entered the tumor cells and stopped their growth.

The study is published in the February 8 issue of Cell.

  • Print
  • Share
  • More GEN News Highlights

Comment on this News:

Name:
Title:
Comment:

HELP US FIGHT SPAMMING ROBOTS by answering the following simple question. It will verify you as a legitimate user wishing to post a comment. Thank you for your cooperation.


CAREER CENTER

Visit the GEN Career Center

for the latest biotech employment opportunities.
Start your search HERE!

visit the Career Center

WEBINARS


view all webinars

GEN and Scintellix bring you the Cryptogram Challenge: RNAi!

PODCASTS

INTERVIEW: NEW PROGNOSTIC GENETIC TEST FOR ADOLESCENT SCOLIOSIS - Interview with Dr. Baron Lonner, director of Scoliosis and Spine Associates ...MORE

MOST POPULAR

News

Articles

Blogs